Skip Navigation

Nephrology Dialysis Transplantation 2007 22(Supplement 9):ix54-ix62; doi:10.1093/ndt/gfm450
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Clark, L. E.
Right arrow Articles by Harris, K.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Clark, L. E.
Right arrow Articles by Harris, K.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2007]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org


Poster Abstracts

The first 150 words of the full text of this article appear below.

How common is early CKD?

 

Reduced eGFR—does this mean CKD?

Laura E. Clark1, Gordon Prescott1, Nicholas Fluck2, William Simpson2, W. Cairns. S. Smith1 and Alison M. Macleod1

1University of Aberdeen and 2NHS Grampian

Chronic kidney disease (CKD) is a growing public health concern. We aimed to establish with increased accuracy the prevalence of CKD in those with at least 1 creatinine ≥150 µmol/l (males) and ≥130 µmol/l (females) in a 6-month period in Grampian (population 500 000).

In a linked study (Poster Dr TZ Ali), 1918 patients could not be classified as having CKD as they did not fulfil our original criteria. 1405 of these have been analysed to date. All available creatinines were converted to eGFR (abbreviated MDRD formula) and patients were grouped according to their likelihood of having CKD. Unlikely n = 80 (5%), Possible n = 245 (17%), Probable n = 933 (66%) and insufficient data n = 147(10%).

Those in the ‘Probable’ group were staged according to their index eGFR. Markers of kidney damage determined from case note review allowed a further 61 patients to be staged (994 in . . . [Full Text of this Article]

T. Z. Ali1, A. M. MacLeod1, J. Townend1, W. C. Smith1, W. Simpson2 and I. H. Khan2

1University of Aberdeen and 2NHS Grampian

Jan Minter1, Kathy Halliday1, Janet Gawthorp1, Paul Mackenzie2 and David Carmichael3

1South East Essex Heart Failure Service, 2Biochemistry Department and 3Renal Unit, Southend Hospital NHS Trust, Prittlewell Chase, Westcliff on Sea, Essex, SS0 0RY

Kirsteen Houston1, Brian Houston1 and David Carmichael2

1Highlands Surgery, 1643 London Road, Leigh on Sea, Essex, SS9 2UT and 2Renal Unit, Southend Hospital NHS Trust, Westcliff on Sea, Essex SS0 0RY

David Preiss1, Ian Godber1, Edmund Lamb2, Neil Dalton3 and Ian Gunn1

1Wishaw General Hospital, 2Kent and Canterbury Hospital and 3Guy's Hospital, London

Louise F. Porter and Ronald S. MacWalter

Stroke Studies Centre, Division Of Medicine And Therapeutics, Ninewells Hospital And Medical School, Dundee, DD1 9SY, Scotland, UK

M. Quinn1, A. Rainey2, K. J. Cairns2, A. H. Marshall2, F. Kee1, G. Savage1 and D. G. Fogarty3

1Department of Public Health and Epidemiology, 2Centre for Statistical Science and Operational Research (CenSSOR), and 3Department of Nephrology, The Queen's University of Belfast

A. Rainey1, M. Quinn2, K. J. Cairns1, A. H. Marshall1, F. Kee2, G. Savage1 and D. G. Fogarty3

1Centre for Statistical Science and Operational Research (CenSSOR), 2Department of Public Health and Epidemiology, and 3Department of Nephrology, The Queen's University of Belfast

B. Conway1,3, G. Ramsay2, A. Webster1, J. Neary1, C. Whitworth1 and J. Harty3

1Department of Nephrology, Royal Infirmary Edinburgh, 2University of Edinburgh and 3Renal Unit, Daisy Hill Hospital, N. Ireland

Walaa W. M. Saweirs and Paddy H. Gibson

Department of Renal Medicine, Royal Infirmary of Edinburgh, Little France, Old Dalkeith Road, Edinburgh, EH16 4SU

P. Giles1, A. Hartland1, P. Rylance2, J. Nicholas2, H. Ashby1, A. Askey3, D. Crothers1 and B. Patel4

1Department of Biochemistry, Walsall Manor Hospital, 2Wolverhampton Renal Unit, 3Walsall GP and 4Locality Lead Pharmacist

John Main1 and Dinah Roy2,3

1James Cook University Hospital, Middlesbrough, 2PEC Chair and 3GP, Sedgefield PCT

Indranil Dasgupta and Hugh Rayner

Heart of England Foundation Trust, Birmingham

N. T. Richards1, M. Eames2, R. Lewis3, M. Mansell4, J. Townend5, S. Thomas6, D. O’Donoghue7 and K. Harris8

1Optimal Renal Care UK, Birmingham, 2Department of Surgery, WLPCT, Market Rasen, 3Department of Nephrology, Queen Alexandra Hospital, Portsmouth, 4Department of Nephrology, Royal Free Hospital, London, 5Department of Cardiology, University Hospital, Birmingham, 6Department of Diabetology, Guys and St Thomas Hospital, London, 7Department of Nephrology, Hope Hospital, Salford and 8Department of Nephrology, ULH, Leicester, UK

Correspondence to: N. T. Richards.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?